The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of B440, an oral Bifidobacterium-engineered WT1 cancer vaccine, in patients with metastatic urothelial cancer.
 
Toshiro Shirakawa
Leadership - Immunorock
Stock and Other Ownership Interests - Immunorock
Honoraria - Immunorock
 
Hideto Ueki
No Relationships to Disclose
 
Yasumasa Kakei
No Relationships to Disclose
 
Takuto Hara
No Relationships to Disclose
 
Jun Teishima
No Relationships to Disclose
 
Keisuke Goto
No Relationships to Disclose
 
Junya Furukawa
No Relationships to Disclose
 
Nobuyuki Hinata
No Relationships to Disclose
 
Hideaki Miyake
Honoraria - Eisai; Merck; MSD; Ono Pharmaceutical; Takeda